Venmax Drugs & Pharmaceuticals Ltd. - Research Center
VENMAX Group (Z) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Mar' 23 | Dec' 22 | Sep' 22 | Jun' 22 | Mar' 22 | |
|---|---|---|---|---|---|
| Sales | - | - | - | - | - |
| Operating profit | -0.08 | -0.03 | -0.06 | -0.02 | -0.03 |
| Interest | - | - | - | - | - |
| Gross profit | 0.19 | 0.02 | -0.01 | 0.03 | 1.95 |
| EPS (Rs) | 0.37 | 0.03 | -0.03 | 0.06 | 3.72 |
Quarterly
results in details
| Mar' 23 | Dec' 22 | Sep' 22 | Jun' 22 | Mar' 22 | |
|---|---|---|---|---|---|
| Other income | 0.27 | 0.05 | 0.05 | 0.05 | 1.98 |
| Stock adjustment | - | - | - | - | - |
| Raw material | - | - | - | - | - |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 0.01 | 0.01 | 0.01 | - | - |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 0.07 | 0.02 | 0.05 | 0.01 | 0.03 |
| Provisions made | - | - | - | - | - |
| Depreciation | - | - | - | - | - |
| Taxation | - | - | - | - | - |
| Net profit / loss | 0.19 | 0.02 | -0.01 | 0.03 | 1.95 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 5.24 | 5.24 | 5.24 | 5.24 | 5.24 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | - | - | - | - | - |
| GPM (%) | - | - | - | - | - |
| NPM (%) | - | - | - | - | - |
Mutual Fund Selector
Find the fund that is right for you
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis